Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IGC Pharma (IGC) Return on Assets (2016 - 2025)

IGC Pharma (IGC) has disclosed Return on Assets for 15 consecutive years, with 0.73% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Assets rose 47.0% to 0.73% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.73%, a 47.0% increase, with the full-year FY2025 number at 0.76%, up 20.0% from a year prior.
  • Return on Assets was 0.73% for Q3 2025 at IGC Pharma, up from 0.76% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.25% in Q2 2021 to a low of 1.3% in Q2 2024.
  • A 5-year average of 0.71% and a median of 0.67% in 2022 define the central range for Return on Assets.
  • Peak YoY movement for Return on Assets: tumbled -64bps in 2024, then surged 54bps in 2025.
  • IGC Pharma's Return on Assets stood at 0.35% in 2021, then tumbled by -89bps to 0.67% in 2022, then tumbled by -53bps to 1.02% in 2023, then rose by 11bps to 0.91% in 2024, then rose by 20bps to 0.73% in 2025.
  • Per Business Quant, the three most recent readings for IGC's Return on Assets are 0.73% (Q3 2025), 0.76% (Q2 2025), and 0.8% (Q1 2025).